Clinical Trials Browser

Phase 2 × ISIS 5132 × Clear all

NCT00003892 2020-04-06

ISIS 5132 in Treating Patients With Metastatic or Recurrent Ovarian Cancer

Phase 2 Completed

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms